ARG42238

anti-PDCD4 antibody

anti-PDCD4 antibody for Flow cytometry,ICC/IF,IHC-Formalin-fixed paraffin-embedded sections,Western blot and Human,Mouse

publication_link Publication1

Overview

Product Description Rabbit Polyclonal antibody recognizes PDCD4
Tested Reactivity Hu, Ms
Tested Application FACS, ICC/IF, IHC-P, WB
Host Rabbit
Clonality Polyclonal
Isotype IgG
Target Name PDCD4
Antigen Species Human
Immunogen Synthetic peptide of Human PDCD4.
Conjugation Un-conjugated
Alternate Names Neoplastic transformation inhibitor protein; Nuclear antigen H731-like; Protein 197/15a; Programmed cell death protein 4; H731

Application Instructions

Application Suggestion
Tested Application Dilution
FACS1:50
ICC/IF1:50 - 1:200
IHC-P1:100 - 1:500
WB1:500 - 1:2000
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.
Positive Control HeLa
Observed Size ~ 52 kDa

Properties

Form Liquid
Purification Affinity purified.
Buffer PBS (pH 7.4), 150 mM NaCl, 0.02% Sodium azide and 50% Glycerol.
Preservative 0.02% Sodium azide
Stabilizer 50% Glycerol
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 18569 Mouse PDCD4

GeneID: 27250 Human PDCD4

Swiss-port # Q53EL6 Human Programmed cell death protein 4

Swiss-port # Q61823 Mouse Programmed cell death protein 4

Gene Symbol PDCD4
Gene Full Name programmed cell death 4 (neoplastic transformation inhibitor)
Background This gene is a tumor suppressor and encodes a protein that binds to the eukaryotic translation initiation factor 4A1 and inhibits its function by preventing RNA binding. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2010]
Function Inhibits translation initiation and cap-dependent translation. May excert its function by hindering the interaction between EIF4A1 and EIF4G. Inhibits the helicase activity of EIF4A. Modulates the activation of JUN kinase. Down-regulates the expression of MAP4K1, thus inhibiting events important in driving invasion, namely, MAPK85 activation and consequent JUN-dependent transcription. May play a role in apoptosis. Tumor suppressor. Inhibits tumor promoter-induced neoplastic transformation. Binds RNA (By similarity). [UniProt]
Cellular Localization Nucleus. Cytoplasm. Note=Shuttles between the nucleus and cytoplasm (By similarity). Predominantly nuclear under normal growth conditions, and when phosphorylated at Ser-457 (PubMed:16357133). [UniProt]
Calculated MW 52 kDa
PTM Polyubiquitinated, leading to its proteasomal degradation. Rapidly degraded in response to mitogens. Phosphorylation of the phosphodegron promotes interaction with BTRC and proteasomal degradation.

Phosphorylated at Ser-67 by RPS6KB1 in response to mitogens; phosphorylation promotes proteasomal degradation of PDCD4. [UniProt]

Images (1) Click the Picture to Zoom In

  • ARG42238 anti-PDCD4 antibody WB image

    Western blot: HeLa cell lysate stained with ARG42238 anti-PDCD4 antibody.

Specific References

Engineering supramolecular dynamics of self-assembly and turnover of oncogenic microRNAs to drive their synergistic destruction in tumor models

WB / Human

Daria Chiglintseva et al.
Biomaterials.,  (2024)

publication_link

 

hr_line